LYNCH DANIEL received a stock award from SPRINGWORKS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/25/2023ACC: 0001104659-23-064648
Director
Since Sep 2019
+18.42K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18.42K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.65K
Price / share
—
Trade value
—
% of position
1.6%
5/24/2023
297.20K→301.85K
Total
Net shares
+4.65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/24/2023 | A · Award | +4.65K | — | — | 1.6% | 297.20K | 301.85K |
| Total | +4.65K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
13.77K shares
Shares
+13.77K
Strike price
32.27
Held after
13.77K
Exercisable
—
5/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock13.77K shares | 5/24/2023 | A · Award | +13.77K | 32.27 | — | 13.77K |